If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Acquisition

18 Jul 2023 07:00

RNS Number : 2908G
Kingspan Group PLC
17 July 2023
 

 

Kingspan Group plc

 

Acquisition

 

Inside Information

 

17 July 2023

 

Kingspan Group plc ("Kingspan") announces the acquisition of a majority stake in Steico SE

 

Kingspan Group plc, the global leader in high performance insulation and building envelope solutions, is pleased to announce that it has entered into an agreement with Schramek GmbH ("Schramek") to acquire c.51% of the shares of Steico SE ("Steico"), with an option to acquire a further c.10% of shares in Steico in the future.

 

Steico is the world leader in natural insulation and wood-based building envelope products, based in Germany and listed on the unofficial markets of several German Stock Exchanges. It has a very well invested asset base, with four large production sites comprising 27 lines situated in Poland and France, including additional capacity nearing completion with up to EUR200m revenue headroom.

 

Steico had audited operating revenues of EUR445m in the 12 months to 31 December 2022 and EBITDA of EUR90m in the same period. As at June 2023, Steico guided 2023 revenues of c.EUR378m at an EBIT margin of 8% - 10% (FY22 14.6%). As at 31 December 2022, Steico had gross assets of EUR509m.

 

The initial consideration for the shares will be EUR35 per share, plus potential deferred consideration of up to a further EUR35 per share contingent on achievement of specified thresholds with a material uplift in profitability. The initial consideration of approximately EUR251.4m will be satisfied on completion, with 25% of the consideration potentially being exchanged for new shares in Kingspan (subject to Kingspan share price at completion). The consideration payable under the put and call option to acquire Schramek's remaining c. 10% in Steico is for a capped amount based on a multiple of future earnings.

The acquisition is expected to be earnings neutral initially, based on Kingspan consensus EPS for 2023 and Steico guidance for 2023.

 

In addition to Steico's existing ambitious growth plans we anticipate significant long term leverage via the Kingspan sales channels. The existing Steico executive management team will be retained in the business, and will continue to manage and develop the business. Upon closing, Kingspan will seek fair representation on Steico's administrative board.

 

The acquisition is conditional on regulatory clearance, and is expected to complete in early 2024. Following completion, Steico will continue to maintain its listings on the German Stock Exchanges.

 

 

Gene Murtagh, Kingspan Chief Executive Officer, commented:

 

"The acquisition of a majority stake in Steico represents an exciting next step in our strategy to provide the full spectrum of insulation products. Its suite of wood-based building envelope solutions broadens our ability to enable our customers to meet their sustainability and energy performance needs. Kingspan's global routes to market, paired with our drive to innovate and widen the applications of Steico's current technologies, are key to our plans to bring Steico bio-based solutions to the next level."

 

Udo Schramek, Steico Chief Executive Officer, stated:

 

"It has been a great honour to lead the team at Steico to become the pre-eminent global supplier of wood-based insulation. We are now entering the next phase of growth and are very enthusiastic about the collaboration opportunities Kingspan brings, in both the existing Steico range and across the Kingspan portfolio and geographies. I am excited about the future for Steico and about being invested in the future growth of both companies."

 

 

Kingspan will hold an investor call at 8.30am IST on Tuesday 18 July 2023 to discuss the acquisition.

 

Operator Assisted Dial-In: United Kingdom (Local): +44 20 4587 0498 United Kingdom (Toll-Free): +44 800 358 1035 Access Code: 022503

 

Further call details will be available shortly on the Investor Relations section of our website www.kingspangroup.com. A recording of this conference call will be made available. For further information about the conference call please contact: ir@kingspan.com or +353 (0)42 969 8000.

 

 

Lorcan Dowd

Company Secretary

+ 353 (0)42 9698000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQEAPXXFDXDEFA
Date   Source Headline
4th May 20074:34 pmRNSDirector/PDMR Shareholding
30th Apr 20074:53 pmRNSVoting Rights and Capital
27th Mar 20072:01 pmRNSAnnual Update Amended
23rd Mar 200712:38 pmRNSAnnual Information Update
15th Mar 20074:11 pmRNSDirector/PDMR Shareholding
5th Mar 20077:02 amRNSFinal Results
11th Jan 200712:31 pmRNSVoting Rights and Capital
22nd Dec 200611:04 amRNSVoting Rights and Capital
22nd Dec 200611:01 amRNSDirector/PDMR Shareholding
18th Dec 20067:01 amRNSTrading Statement
28th Nov 20063:00 pmRNSTrading Update Notification
6th Nov 20063:43 pmRNSAcquisition Update
26th Oct 200611:19 amRNSAcquisition Update
19th Sep 20064:56 pmRNSDirector/PDMR Shareholding
6th Sep 200610:00 amRNSDirector/PDMR Shareholding
5th Sep 20067:02 amRNSInterim Results
4th Jul 20062:00 pmRNSAmended Blocklisting Return
4th Jul 20062:00 pmRNSDirector/PDMR Shareholding
3rd Jul 20069:00 amRNSBlocklisting Interim Review
26th Jun 200610:05 amRNSAcquisition
19th Jun 200610:20 amRNSDirector/PDMR Shareholding
14th Jun 20063:10 pmRNSDirector/PDMR Shareholding
9th Jun 20067:00 amRNSAnalyst Site Visit
1st Jun 20062:07 pmRNSDirector/PDMR Shareholding
26th May 20062:31 pmRNSDirector/PDMR Shareholding
25th May 200612:53 pmRNSAGM Results
25th May 20067:00 amRNSAGM Statement
23rd May 20065:02 pmRNSChairmanStatementNotification
9th May 20067:01 amRNSStatement re Press Comment
3rd May 200610:52 amRNSDirector/PDMR Shareholding
11th Apr 20064:38 pmRNSDirector/PDMR Shareholding
31st Mar 20064:52 pmRNSAnnual Information Update
30th Mar 20065:04 pmRNSHolding(s) in Company
16th Mar 20065:28 pmRNSDirector/PDMR Shareholding
6th Mar 20067:01 amRNSFinal Results
15th Feb 200611:32 amRNSHolding(s) in Company
10th Feb 20065:12 pmRNSHolding(s) in Company
31st Jan 200611:13 amRNSBlocklisting Review
3rd Jan 20067:01 amRNSDirectorate Change
21st Dec 20059:51 amRNSUp-date Analyst's Call
7th Dec 20059:45 amRNSTrading Statement Notificatio
29th Nov 20054:37 pmRNSBlock Listing Application
28th Nov 200510:49 amRNSSIXTYK Housing Award
18th Nov 20055:21 pmRNSDirector/PDMR Shareholding
28th Oct 20053:46 pmRNSDirector/PDMR Shareholding
27th Oct 20055:04 pmRNSHolding(s) in Company
21st Oct 20057:01 amRNSAward Win
11th Oct 20054:17 pmRNSDirector/PDMR Shareholding
4th Oct 20052:46 pmRNSDirector/PDMR Shareholding
28th Sep 20053:40 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.